Location: Larkspur, CA
CIK: 0001425738 · Show all filings
Period: Q1 2021 (← Previous) (Next →)
Filing Date: May 17, 2021
Total Value: $7.1B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| FATE | FATE THERAPEUTICS INC | 12,957,222 | $1.068B | 15.0% | $13.22 | +624.6% | COM | 31189P102 |
| — | ALLAKOS INC | 2,419,418 | $278M | 3.9% | $61.43 | — | COM | 01671P100 |
| — | IGM BIOSCIENCES INC | 3,425,455 | $263M | 3.7% | $22.36 | — | COM | 449585108 |
| ARGX | ARGENX SE | 849,845 | $234M | 3.3% | $87.46 | — | SPONSORED ADR | 04016X101 |
| FOLD | AMICUS THERAPEUTICS INC | 21,114,114 | $209M | 2.9% | $10.61 | +45.9% | COM | 03152W109 |
| BEAM | BEAM THERAPEUTICS INC | 2,532,523 | $203M | 2.9% | $25.01 | +280.4% | COM | 07373V105 |
| — | DECIPHERA PHARMACEUTICALS IN | 4,351,644 | $195M | 2.7% | $30.83 | — | COM | 24344T101 |
| — | INVITAE CORP | 4,852,163 | $185M | 2.6% | $41.38 | — | COM | 46185L103 |
| ADCT | ADC THERAPEUTICS SA | 7,308,418 | $178M | 2.5% | $37.80 | -23.4% | SHS | H0036K147 |
| STTK | SHATTUCK LABS INC | 5,619,914 | $164M | 2.3% | $32.14 | +30.7% | COM | 82024L103 |
| — | MEDAVAIL HOLDINGS INC | 11,724,726 | $164M | 2.3% | $15.05 | — | COM | 58406B103 |
| — | OAK STR HEALTH INC | 2,930,411 | $159M | 2.2% | $54.16 | — | COM | 67181A107 |
| KRYS | KRYSTAL BIOTECH INC | 2,060,132 | $159M | 2.2% | $43.09 | +68.7% | COM | 501147102 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 829,159 | $136M | 1.9% | $164.55 | 0.0% | SHS USD | G50871105 |
| — | SEAGEN INC | 937,045 | $130M | 1.8% | $138.86 | — | COM | 81181C104 |
| PLRX | PLIANT THERAPEUTICS INC | 3,207,193 | $126M | 1.8% | $26.54 | +22.4% | COM | 729139105 |
| REPL | REPLIMUNE GROUP INC | 4,118,212 | $126M | 1.8% | $21.73 | +72.4% | COM | 76029N106 |
| MDT | MEDTRONIC PLC | 979,108 | $116M | 1.6% | $101.70 | 0.0% | SHS | G5960L103 |
| SRRK | SCHOLAR ROCK HLDG CORP | 2,176,628 | $110M | 1.6% | $18.39 | +200.8% | COM | 80706P103 |
| NRIX | NURIX THERAPEUTICS INC | 3,314,117 | $103M | 1.5% | $27.59 | +37.1% | COM | 67080M103 |
| KYMR | KYMERA THERAPEUTICS INC | 2,603,139 | $101M | 1.4% | $30.53 | +97.2% | COM | 501575104 |
| — | ATARA BIOTHERAPEUTICS INC | 6,885,233 | $98.87M | 1.4% | $23.37 | — | COM | 046513107 |
| STOK | STOKE THERAPEUTICS INC | 2,544,062 | $98.81M | 1.4% | $26.54 | +114.5% | COM | 86150R107 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 2,221,044 | $96.37M | 1.4% | $37.29 | +15.4% | COM | 98943L107 |
| ANNX | ANNEXON INC | 3,458,830 | $96.29M | 1.4% | $23.46 | +17.2% | COM | 03589W102 |
| — | GENMARK DIAGNOSTICS INC | 3,589,342 | $85.78M | 1.2% | $14.71 | — | COM | 372309104 |
| LIVN | LIVANOVA PLC | 1,119,830 | $82.56M | 1.2% | $71.35 | 0.0% | SHS | G5509L101 |
| — | REPARE THERAPEUTICS INC | 2,665,496 | $81.8M | 1.2% | $31.32 | — | COM | 760273102 |
| — | NGM BIOPHARMACEUTICALS INC | 2,751,815 | $80M | 1.1% | $29.07 | — | COM | 62921N105 |
| DXCM | DEXCOM INC | 222,458 | $79.95M | 1.1% | $93.87 | 0.0% | COM | 252131107 |
| RGNX | REGENXBIO INC | 2,340,313 | $79.83M | 1.1% | $33.61 | +26.9% | COM | 75901B107 |
| — | TCR2 THERAPEUTICS INC | 3,610,788 | $79.73M | 1.1% | $18.64 | — | COM | 87808K106 |
| — | IMMUNOGEN INC | 9,688,066 | $78.47M | 1.1% | $5.36 | — | COM | 45253H101 |
| — | EPIZYME INC | 8,824,366 | $76.86M | 1.1% | $10.46 | — | COM | 29428V104 |
| — | AKERO THERAPEUTICS INC | 2,513,746 | $72.92M | 1.0% | $28.85 | — | COM | 00973Y108 |
| ALXO | ALX ONCOLOGY HLDGS INC | 978,600 | $72.16M | 1.0% | $51.82 | +51.9% | COM | 00166B105 |
| — | NEVRO CORP | 516,795 | $72.09M | 1.0% | $101.97 | — | COM | 64157F103 |
| AVIR | ATEA PHARMACEUTICALS INC | 1,158,082 | $71.51M | 1.0% | $32.23 | +109.6% | COM | 04683R106 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 3,387,788 | $69.79M | 1.0% | $11.02 | +108.3% | COM NEW | 15117B202 |
| CI | CIGNA CORP NEW | 280,057 | $67.7M | 1.0% | $173.00 | +18.0% | COM | 125523100 |
| SLQT | SELECTQUOTE INC | 2,005,054 | $59.17M | 0.8% | $22.68 | +15.6% | COM | 816307300 |
| — | NEOLEUKIN THERAPEUTICS INC | 4,117,569 | $50.69M | 0.7% | $11.83 | — | COM | 64049K104 |
| CRL | CHARLES RIV LABS INTL INC | 166,679 | $48.31M | 0.7% | $277.97 | 0.0% | COM | 159864107 |
| NUVB | NUVATION BIO INC | 4,541,009 | $47.45M | 0.7% | $11.18 | 0.0% | COM CL A | 67080N101 |
| ELV | ANTHEM INC | 130,405 | $46.81M | 0.7% | $286.17 | +5.1% | COM | 036752103 |
| PRTA | PROTHENA CORP PLC | 1,857,072 | $46.65M | 0.7% | $18.81 | 0.0% | SHS | G72800108 |
| ICUI | ICU MED INC | 224,154 | $46.05M | 0.6% | $197.02 | +7.2% | COM | 44930G107 |
| BIIB | BIOGEN INC | 162,847 | $45.56M | 0.6% | $281.08 | -4.1% | COM | 09062X103 |
| — | ALLOVIR INC | 1,943,587 | $45.48M | 0.6% | $27.50 | — | COM | 019818103 |
| GMAB | GENMAB A/S | 1,332,212 | $43.74M | 0.6% | $32.83 | — | SPONSORED ADS | 372303206 |
| — | LAVA THERAPEUTICS NV | 2,824,409 | $42.9M | 0.6% | $15.19 | — | SHS | N51517105 |
| UNH | UNITEDHEALTH GROUP INC | 114,376 | $42.56M | 0.6% | $308.19 | +3.7% | COM | 91324P102 |
| — | ATRECA INC | 2,490,568 | $38.18M | 0.5% | $15.87 | — | CL A COM | 04965G109 |
| — | AMEDISYS INC | 132,980 | $35.21M | 0.5% | $173.26 | — | COM | 023436108 |
| — | ACHILLES THERAPEUTICS PLC | 2,088,089 | $34.56M | 0.5% | $16.55 | — | SPONSORED ADS | 00449L102 |
| RCEL | AVITA MEDICAL INC | 1,668,327 | $33.07M | 0.5% | $24.93 | -6.7% | COM | 05380C102 |
| — | CATALENT INC | 311,619 | $32.82M | 0.5% | $51.95 | — | COM | 148806102 |
| — | ZYMEWORKS INC | 985,700 | $31.13M | 0.4% | $38.68 | — | COM | 98985W102 |
| — | PPD INC | 821,092 | $31.07M | 0.4% | $20.80 | — | COM | 69355F102 |
| — | HOOKIPA PHARMA INC | 1,842,902 | $24.79M | 0.3% | $6.73 | — | COM | 43906K100 |
| IMTX | IMMATICS N.V | 2,082,814 | $23.35M | 0.3% | $10.53 | +7.7% | SHS | N44445109 |
| ARDX | ARDELYX INC | 3,514,100 | $23.26M | 0.3% | $6.08 | +13.0% | COM | 039697107 |
| — | GRITSTONE ONCOLOGY INC | 2,448,158 | $23.09M | 0.3% | $13.39 | — | COM | 39868T105 |
| BVS | BIOVENTUS INC | 1,500,000 | $22.92M | 0.3% | $14.24 | 0.0% | COM CL A | 09075A108 |
| — | ITAMAR MED LTD | 918,900 | $22.01M | 0.3% | $15.29 | — | SPONSORED ADS | 465437101 |
| — | 1LIFE HEALTHCARE INC | 562,314 | $21.98M | 0.3% | $19.17 | — | COM | 68269G107 |
| INNV | INNOVAGE HLDG CORP | 850,000 | $21.92M | 0.3% | $24.64 | 0.0% | COM | 45784A104 |
| STXS | STEREOTAXIS INC | 3,241,603 | $21.78M | 0.3% | $3.05 | +94.4% | COM NEW | 85916J409 |
| — | VESPER HEALTHCARE ACQSTN COR | 1,982,749 | $21.41M | 0.3% | $11.06 | — | COM CL A | 92538T104 |
| CTSO | CYTOSORBENTS CORP | 2,127,631 | $18.47M | 0.3% | $9.04 | +5.4% | COM NEW | 23283X206 |
| QTRX | QUANTERIX CORP | 300,000 | $17.54M | 0.2% | $67.60 | 0.0% | COM | 74766Q101 |
| PROF | PROFOUND MED CORP | 845,674 | $17.03M | 0.2% | $14.70 | +63.1% | COM NEW | 74319B502 |
| — | YUMANITY THERAPEUTICS INC | 611,003 | $11.06M | 0.2% | $17.00 | — | COM | 98872L102 |
| QURE | UNIQURE NV | 284,160 | $9.573M | 0.1% | $46.21 | -22.4% | SHS | N90064101 |
| — | DYNAVAX TECHNOLOGIES CORP | 882,814 | $8.678M | 0.1% | $8.87 | — | COM NEW | 268158201 |
| CABA | CABALETTA BIO INC | 696,378 | $7.73M | 0.1% | $11.85 | +3.1% | COM | 12674W109 |
| — | XERIS PHARMACEUTICALS INC | 1,712,304 | $7.722M | 0.1% | $17.23 | — | COM | 98422L107 |
| — | AYALA PHARMACEUTICALS INC | 667,816 | $7.286M | 0.1% | $10.03 | — | COM | 05465V108 |
| STIM | NEURONETICS INC | 500,000 | $6.185M | 0.1% | $15.33 | 0.0% | COM | 64131A105 |
| — | TALIS BIOMEDICAL CORP | 400,000 | $5.14M | 0.1% | $12.85 | — | COM | 87424L108 |
| — | APREA THERAPEUTICS INC | 694,918 | $3.544M | 0.0% | $45.89 | — | COM | 03836J102 |
| — | SYROS PHARMACEUTICALS INC | 212,291 | $1.588M | 0.0% | $11.34 | — | COM | 87184Q107 |
| OVID | OVID THERAPEUTICS INC | 121,950 | $490K | 0.0% | $8.46 | -60.7% | COM | 690469101 |
| WVE | WAVE LIFE SCIENCES LTD | 79,018 | $443K | 0.0% | $25.65 | -62.5% | SHS | Y95308105 |
| — | TRICIDA INC | 54,758 | $290K | 0.0% | $29.54 | — | COM | 89610F101 |
| — | CASTLIGHT HEALTH INC | 10,229 | $15,000 | 0.0% | $4.20 | — | CL B | 14862Q100 |